Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

204.89 USD +1.07 (+0.52%)
Official Closing Price Updated: 7:56 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Global COVID cases top 113 million as FDA committee meets to vote on J&J vaccine
The number of confirmed cases of the coronavirus-borne illness COVID-19 climbed above 113 million on Friday, amid a flurry of positive vaccine news and as a regulatory advisory committee gathered to... 
Tags JNJ LLY SPX
From MarketWatch
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Earnings MYGN LHDX
From Benzinga
US Government Calls For Additional Eli Lilly COVID-19 Antibody Therapy
The U.S. government hasagreed to purchase a minimumof 100,000 doses ofEli Lilly and Co's(NYSE:LLY) ... 
Tags Market News Benzinga Biotech
From Benzinga
Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning
The battle against Covid-19 is about to get uglier. Coronavirus mutations threaten to undercut a year's worth of work upholding Covid stocks like Pfizer, Moderna and Regeneron Pharmaceuticals. 
From Investor's Business Daily
Are These Top Health Care Stocks Worth Watching Ahead Of March?
Tags Market News
From Stockmarket.com
RLFTF: Why Little-Known Relief Therapeutics Is Climbing Today
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Shares of little-known biopharma firm Relief Therapeutics gained on... 
Tags RLFTF CDMO LLY
From InvestorPlace
Stocks Generating Improved Relative Strength: Eli Lilly
Eli Lilly shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Veru Files US Application For TADFIN Combo For Prostate Enlargement
Veru Inc(NASDAQ:VERU) hassubmitted a 505(b)(2) New Drug Applicationwith the FDA for TADFIN (tadalafil 5mg and ... 
Tags Benzinga News MRK
From Benzinga
Should You Follow Cathie Wood Into This Coronavirus Stock?
This latest pick has been sluggish so far -- but the long-term opportunity may be huge. 
Tags ARKF Market News ARKG
From Motley Fool
3 Reasons Rigel Pharmaceuticals Stock Can Continue Soaring
Here's why this stock's big run-up in recent months could be just the beginning. 
Tags LLY Market News RIGL
From Motley Fool
Precision Bio's ARCUS Gene Editing Platform Is Safe, Durable; Long-Term Animal Study Shows
Precision BioSciences Inc(NASDAQ:DTIL) has announcedthree-year follow-up datashowing long-term stable ... 
Tags DTIL Benzinga Small Cap
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags IMCR PFE Benzinga
From Benzinga
RIGL Stock: Why Rigel Pharmaceuticals Is Climbing Today
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>A newly announced deal between Rigel Pharmaceuticals and sector behemoth... 
Tags Today's Market RIGL Market News
From InvestorPlace
Why Rigel Pharmaceuticals Stock Is Jumping Today
The company is teaming up with Eli Lilly on the development of a promising immune disease drug. 
Tags RIGL Market News LLY
From Motley Fool
Lilly Strikes Licensing Deal With Rigel In Push Toward Neurological, Immunological Therapies
Eli Lilly And Co (NYSE: LLY) announced a licensing deal Thursday with smaller biopharma Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) that ... 
Tags Trading Ideas LLY DNLI
From Benzinga
Return On Capital Employed Overview: Eli Lilly
Looking at Q4, Eli Lilly (NYSE:LLY) earned $1.99 billion, a 55.84% increase from the preceding quarter. Eli Lilly also posted a total of ... 
Tags News Market News Earnings
From Benzinga
Penny Stocks To Buy With Analysts Targeting 76%-209% Upside
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SWAV Offerings Biotech
From Benzinga
Dow futures retreat ahead of weekly jobless claims report
Futures contracts on U.S. stock-market indexes head modestly lower Thursday morning as investors watch for the latest weekly update on the state of the U.S. labor market amid the COVID pandemic. 
Tags AMC DJIA GME
From MarketWatch
Eli Lilly's Tirzepatide Reduces A1C And Body Weight, Late-Stage Studies In Type 2 Diabetes Show
Eli Lilly And Co(NYSE:LLY) haveannounced topline resultsfrom two Phase 3 ... 
Tags Benzinga Diabetes Phase 3 Study
From Benzinga
Noteworthy ETF Outflows: USMV, NEE, LLY, ACN
Symbols mentioned in this story: USMV, NEE, LLY, ACN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Large Cap Biopharma Stalled With Move to Small Caps and Reflation Trade
Defensive large-cap biopharma stocks stalled as traders moved out on the risk curve seeking faster gains. 
Tags Stocks / Equities ETFs Healthcare
From Blogs - TalkMarkets
Week In Review: Suzhou's Adagene Raises $140 Million In US IPO To Develop Oncology Drugs
Adagene, a Suzhou immunoncology biopharma, completed a $140 million NASDAQ IPO and climbed 56% higher in open market trading. Adagene has a market capitalization of about $1 billion. 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
3 Stocks to Buy and Hold for the Next Decade: Eli Lilly, HCA Healthcare, and Seagen
If there is one lesson the COVID-19 pandemic has taught humanity, it is to value our health over all else. 
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
Week in Review: Suzhou's Adagen Raises $140 Million in US IPO to Develop Oncology Drugs
Deals and Financings Adagene, a Suzhou immunoncology biopharma, completed a $140 million NASDAQ IPO and climbed 56% higher to a $1 billion valuation; Shanghai Nuance Pharma in-licensed Greater China... 
From ChinaBio® Today
Week in Review: Suzhou's Adagen Raises $140 Million in US IPO to Develop Oncology Drugs
Deals and Financings Adagene, a Suzhou immunoncology biopharma, completed a $140 million NASDAQ IPO and climbed 56% higher to a $1 billion valuation; Shanghai Nuance Pharma in-licensed Greater China... 
From ChinaBio® Today
Week in Review: Suzhou's Adagene Raises $140 Million in US IPO to Develop Oncology Drugs
Deals and Financings Adagene, a Suzhou immunoncology biopharma, completed a $140 million NASDAQ IPO and climbed 56% higher to a $1 billion valuation; Shanghai Nuance Pharma in-licensed Greater China... 
From ChinaBio® Today
Can Coronavirus Antibodies Overcome Their Obstacles?
Issues with timing, delivery, and manufacturing make the treatments less promising. 
Tags LLY VIR REGN
From Motley Fool
Should Investors Be Watching These Top Coronavirus Stocks Right Now?
Tags Market News
From Stockmarket.com
Could Cassava Sciences Be a Millionaire-Maker Stock?
This company's experimental Alzheimer's disease drug looks very promising, but there are a few key caveats. 
Tags SAVA PFE HLUKF
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.